Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.
Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.
A study found no survival differences between high-grade UTUC patients who at the time of radical nephroureterectomy achieved low-grade disease following neoadjuvant chemotherapy and those who had inherently low-stage disease and did not receive chemotherapy.
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.
It may be important to sequence ETV6in patients with inherited thrombocytopenia or malignancy and to schedule regular follow-ups to check for secondary cancers.
Engaging patients in a CRCMP for CINV allowed for rapid assessment of PROs by a pharmacist, reducing ED visits, hospitalizations, and urgent care use.
Researchers were able to accurately predict financial toxicity among women undergoing mastectomy or lumpectomy for breast cancer.
Margin size was not associated with locoregional recurrence for patients with breast cancer who underwent breast-conserving surgery and neoadjuvant chemotherapy.
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency.
The Food and Drug Administration (FDA) has approved the combination of Opdivo (nivolumab; Bristol Myers Squibb) plus Yervoy (ipilimumab; Bristol Myers Squibb) and 2 cycles of platinum-doublet chemotherapy, for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations.
Findings from this study support use of serial MRD monitoring during lenalidomide maintenance therapy to identify patients likely to benefit from prolonged treatment.
An additional notable finding from this study was that the absence of specialist care was associated with higher healthcare costs among patients with MPNs.
Delay in surgery for early-stage cervical cancer was not associated with worse short-term outcomes, supporting the suggestion to delay surgery in COVID-19 hotspots.
Novel treatment options are needed to improve outcomes for patients with TP53</i-mutated myeloid neoplasms.
The incidence of DLBCL among Hispanic individuals and CLL among non-Hispanic black individuals was associated with urban status.